SCA
MEDP icon

Snowden Capital Advisors’s Medpace MEDP Stock Holding History

Snowden Capital Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$317K Sell
661
-121
-15% -$62K 0.01% 1000
2025
Q4 		$439K Sell
782
-74
-9% -$42K 0.01% 869
2025
Q3 		$440K Sell
856
-110
-11% -$48K 0.01% 846
2025
Q2 		$303K Sell
966
-23
-2% -$6.91K 0.01% 1000
2025
Q1 		$301K Buy
989
+322
+48% +$108K 0.01% 973
2024
Q4 		$222K Buy
+667
New +$226K 0.01% 1118
2024
Q3 		– Sell
-555
Closed -$229K – 1246
2024
Q2 		$229K Sell
555
-27
-5% -$10.7K 0.01% 1087
2024
Q1 		$235K Sell
582
-95
-14% -$33.4K 0.01% 1068
2023
Q4 		$208K Buy
+677
New +$183K 0.01% 1067

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Snowden Capital Advisors's MEDP Position: Q1 2026 in Review

Snowden Capital Advisors reduced its Medpace (MEDP) stake by 15% in Q1 2026, selling an estimated $62K and leaving 661 shares worth $317K. The position accounts for 0.01% of the portfolio, ranked #1000.

Snowden Capital Advisors first reported a position in MEDP in Q4 2023 and has held it in 9 quarters since. The position peaked at $440K in Q3 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Snowden Capital Advisors held 661 shares of Medpace worth $317K as of Q1 2026.
  • Snowden Capital Advisors sold 121 Medpace shares in Q1 2026, an estimated $62K.
  • Medpace made up 0.01% of Snowden Capital Advisors's portfolio in Q1 2026, its #1000 holding.
  • Snowden Capital Advisors first reported a position in Medpace in Q4 2023 and has held it in 9 quarters since.
  • Snowden Capital Advisors's Medpace position peaked at $440K in Q3 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.